news & meetings - latest announcements & happenings | FAPvoice

welcome to FAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Mother of woman living with rare bowel condition: She is such a fighter

OLIVIA Jobes was just four years old when she was diagnosed with a rare and dangerous bowel condition normally only seen in older people. Here, her mother Helen, 46, tells our reporter how she and her husband Richard, 46, a bicycle shop owner from South Cave in East Yorkshire, fought for a diagnosis and how proud she is of Olivia, now 15. Helen says: “When I watch our daughter Olivia practising her golf swing, or hear her listening to her friends’ problems on the phone, I know how blessed we all are to have this loving, loyal girl in our lives. Yet when she was four, we were in danger of losing her to a horrible condition that usually affects people in middle age.  
Jun 6, 2017
clinical trials

Independent Data Monitoring Committee Recommends Continuation of Cancer Prevention Pharmaceuticals’ Phase 3 Trial for Familial Adenomatous Polyposis Patients

Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced today that an Independent Data Monitoring Committee (IDMC), following a planned interim futility analysis, recommended continuation of the company’s pivotal Phase 3 trial, CPP FAP-310, evaluating CPP-1X/sulindac for adults with familial adenomatous polyposis (FAP). FAP is a rare genetic disease that if left untreated progresses to colorectal cancer in nearly 100% of patients. For most FAP patients, current medical practice recommends a lifetime of periodic monitoring as well as surgeries (FAP-related events). These FAP-related events include surgical removal of the colon, rectum, surgical pouch, duodenum, and/or high risk adenomas.
Jun 12, 2017